Cargando…
Contribution of the Skin–Gut Axis to Immune-Related Adverse Events with Multi-System Involvement
SIMPLE SUMMARY: Increasing numbers of cancer patients are treated with immunotherapy that activates their immune systems to control or even eliminate tumors. However, a substantial proportion of patients experience adverse events mediated by the unleashed immune system. The skin is one of the most f...
Autores principales: | Kuo, Alyce M., Kraehenbuehl, Lukas, King, Stephanie, Leung, Donald Y. M., Goleva, Elena, Moy, Andrea P., Lacouture, Mario E., Shah, Neil J., Faleck, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221505/ https://www.ncbi.nlm.nih.gov/pubmed/35740660 http://dx.doi.org/10.3390/cancers14122995 |
Ejemplares similares
-
Management of immune-related cutaneous adverse events with dupilumab
por: Kuo, Alyce Mei-Shiuan, et al.
Publicado: (2023) -
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events
por: Gu, Stephanie L., et al.
Publicado: (2023) -
High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
por: Kuo, Alyce M., et al.
Publicado: (2022) -
Hand hygiene impact on the skin barrier in health care workers and individuals with atopic dermatitis
por: Hui-Beckman, Jessica, et al.
Publicado: (2022) -
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis
por: Kraehenbuehl, Lukas, et al.
Publicado: (2023)